Tianan Xin (天安欣)天安欣
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 哈尔滨三联药业股份有限公司Chinese legal name: 哈尔滨三联药业股份有限公司
主要成分Active Ingredients
- 环磷腺苷Huanlin Xiangan
药物知识说明
环磷腺苷是一种在国家药监局注册认定的药品。该药品含有环磷腺苷-f8b387c7等成分。
该药品关联的活性成分包括：环磷腺苷Huanlin Xiangan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：哈尔滨三联药业股份有限公司Chinese legal name: 哈尔滨三联药业股份有限公司。
您可以探索含有相同成分的其他药品：环磷腺苷-f8b387c7成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 天安欣) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 环磷腺苷Huanlin Xiangan.
Manufacturers recorded for this product: 哈尔滨三联药业股份有限公司Chinese legal name: 哈尔滨三联药业股份有限公司.
Explore other medicines containing the same ingredient: 环磷腺苷 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 天安欣Recorded Chinese name: 天安欣
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml:20mg2 mL:20 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 哈尔滨三联药业股份有限公司Chinese legal name: 哈尔滨三联药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20051533
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20051533
Manufacturer
Chinese legal name: 哈尔滨三联药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20051533
生产企业
哈尔滨三联药业股份有限公司(国产)
适应症
1.本品用于心绞痛、心肌梗死、心肌炎及心源性休克。 2.对改善风湿性心脏病的心悸、气急、胸闷等症状有一定的作用。 3.对急性白血病结合化疗可提高疗效，亦可用于急性白血病的诱导缓解。 4.此外，对老年慢性支气管炎、各种肝炎和银屑病也有一定疗效。
用法用量
1.静脉注射，一次20mg，溶于20ml0.9%氯化钠注射液中推注，一日2次。 2.静脉滴注，本品40mg溶于250～500ml5%葡萄糖注射液中，一日1次。冠心病以15日为一疗程，可连续应用2～3疗程;白血病以一个月为一疗程;银屑病以2～3周为一疗程，可延长使用到4～7周，每日用量可增加至60～80mg。
不良反应
1.偶见发热和皮疹。
2.大剂量静脉注射(按体重每分钟达0.5mg/kg)时，可引起腹痛、头痛、肌痛、睾丸痛、背痛、四肢无力、恶心、手脚麻木、高热等。
禁忌
1.对药物中任一成分过敏者。
2.本品禁与氨茶碱同时静脉给药。
注意事项
1.滴注不应太快，用量150mg以上应在90分钟以上滴完。
2.如遇心悸、心慌，应停止用药，停药后症状自行消失。
规格
2ml:20mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.